Barely Significant
← all excerpts

Evaluation of Imatinib and Its Combination With Albendazole Against <i>Echinococcus granulosus</i> Protoscoleces and Microcysts In Vitro.

J Parasitol Res · 2026 · PMC13317143 · PMID 42381970

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

showed a trendp > 0.05actually significant
A comparison of 5 μ g/mL imatinib with 10 μ g/mL albendazole also showed a trend toward higher efficacy for imatinib, with complete protoscoleces death occurring on Days 30 and 33, respectively ( p > 0.05).

also in 35,913 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.